Home > Clinical Trials by Conditions > "M" Clinical Trial Conditions > Myocardial Infarction Clinical Trials
Myocardial Infarction Clinical Trials
A safety and efficacy trial evaluating the use of fondaparinux in percutaneous coronary intervention (PCI)
Condition: organon_clinical_trials.html
Organon
A safety, efficacy trial evaluating the early administration of abciximab and reteplase combination treatment in PCI
Condition: centocor_clinical_trials.html
Centocor
Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
ARISE - Aggressive Reduction of Inflammation Stops Events
Condition: atherogenics_clinical_trials.html
AtheroGenics
Aspirin-Myocardial Infarction Study (AMIS)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Assessment of a B-Mode Ultrasound Technique for the Measurement of Carotid Artery Intima-Media Thickness
Condition: national_institute_of_allergy_and_infectious_diseases_niaid_clinical_trials.html
National Institute of Allergy and Infectious Diseases (NIAID)
Autologous Cultured Myoblasts (BioWhittaker) Transplanted via Myocardial Injection
Condition: bioheart_inc_clinical_trials.html
Bioheart, Inc.
Azithromycin and Coronary Events Study (ACES)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Beta-Blocker Heart Attack Trial (BHAT)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Carotid Atherosclerosis Follow-up Study
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors
Condition: warren_g_magnuson_clinical_center_cc_clinical_trials.html
Warren G Magnuson Clinical Center (CC)
Coronary Disease Morbidity and Mortality in a Population
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Coronary Drug Project
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Emergency Cardiac Care
Condition: national_institute_of_nursing_research_ninr_clinical_trials.html
National Institute of Nursing Research (NINR)
Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25)
Condition: aventis_pharmaceuticals_clinical_trials.html
Aventis Pharmaceuticals
Evaluation of SC-V Versus Conventional CPR
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Flavonoids and Cardiovascular Disease
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Fondaparinux Use in a Broad Range of Patients with ST-segment Elevation Acute Myocardial Infarction (MI)
Condition: organon_clinical_trials.html
Organon
Genetics of CRP in Families with Myocardial Infarction
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Health Professionals Follow-up Study
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Home Automatic External Defibrillator Trial -- HAT
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Homocyst(e)ine, Vitamin Status, and CVD Risk
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Homocysteine and Progression of Atherosclerosis
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Honolulu Heart Program
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Incidence of Diabetes and Cardiovascular Disease in Mexican Americans
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Infection and Cardiovascular Disease
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Inflammation, Infection, and Future Cardiovascular Risk
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Look AHEAD: Action for Health in Diabetes
Condition: national_institute_of_diabetes_and_digestive_and_kidney_diseases_niddk_clinical_trials.html
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
MCC-135 as Adjunct Therapy to Primary Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction Patients
Condition: mitsubishi_pharma_corporation_clinical_trials.html
Mitsubishi Pharma Corporation
Minnesota Heart Health Program
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Montreal Heart Attack Readjustment Trial (M-HART)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
MRI Evaluation of Chest Pain
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Multi-Ethnic Study of Atherosclerosis (MESA)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Multicenter Investigation of Limitation of Infarct Size (MILIS)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Multicenter Study of Silent Myocardial Ischemia (MSSMI)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Myocardial Infarction Triage and Intervention Project (MITI)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
MYOHEART™ (Myogenesis Heart Efficiency and Regeneration Trial)
Condition: bioheart_inc_clinical_trials.html
Bioheart, Inc.
NHLBI Type II Coronary Intervention Study
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Nurses' Health Study
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Observational Aspirin Use and CVD in the Physicians' Health Study
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Occluded Artery Trial (OAT)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Open Study of enoxaparin vs. unfractionated heparin in patients with acute coronary syndromes
Condition: aventis_pharmaceuticals_clinical_trials.html
Aventis Pharmaceuticals
Outcome Study ONTARGET
Condition: boehringer_ingelheim_pharmaceuticals_clinical_trials.html
Boehringer Ingelheim Pharmaceuticals
Periodontitis and Cardiovascular Events or "PAVE"
Condition: national_institute_of_dental_and_craniofacial_research_nidcr_clinical_trials.html
National Institute of Dental and Craniofacial Research (NIDCR)
Predictors of Cardiovascular Disease in the Elderly
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Program on Surgical Control of Hyperlipidemias (POSCH)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Protein S and Myocardial Infarction
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Public Access Defibrillation (PAD) Community Trial
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Rapid Early Action for Coronary Treatment (REACT)
Condition: national_heart_lung_and_blood_institute_nhlbi_clinical_trials.html
National Heart, Lung, and Blood Institute (NHLBI)
Myocardial Infarction Clinical Trials
|
